Literature DB >> 17601626

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.

Hertzel C Gerstein1, Pasqualina Santaguida, Parminder Raina, Katherine M Morrison, Cynthia Balion, Dereck Hunt, Hossein Yazdi, Lynda Booker.   

Abstract

BACKGROUND: Several estimates of the risk of progression to diabetes in people with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) have been reported.
OBJECTIVE: To provide an estimate of the risk of progression to diabetes and regression to normoglycemia in these populations.
DESIGN: Systematic overview and meta-analysis of prospective cohort studies published from 1979 until 2004.
SETTING: Global cohort studies. PATIENTS: People with IFG or IGT detected by a screening oral glucose tolerance test. MEASUREMENTS: Fasting and post-load plasma glucose levels.
RESULTS: The absolute annual incidence of diabetes in individuals with various categories of IFG or IGT varied from 5 to 10%. Compared to normoglycemic people the meta-analyzed relative risk and 95% confidence interval for diabetes was: 6.35 (4.87-7.82) in people with IGT; 5.52 (3.13-7.91) in people with isolated IGT; 4.66 (2.47-6.85) in people with IFG; 7.54 (4.63-10.45) in people with isolated IFG; and 12.13 (4.27-20.00) in people with both IFG and IGT. People with IGT were 0.33 times as likely to be normoglycemic after 1 year compared to people with normal glucose tolerance (95% CI 0.23-0.43). LIMITATIONS: Studies that used differing criteria for IFG and IGT were included, and participants were classified on the basis of only one test.
CONCLUSION: IFG and IGT are associated with similar, high relative risk for incident diabetes. The combined abnormality of IFG plus IGT is associated with the highest relative risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601626     DOI: 10.1016/j.diabres.2007.05.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  185 in total

Review 1.  Lifestyle interventions in preventing new type 2 diabetes in Asian populations.

Authors:  Pietro Amedeo Modesti; Giorgio Galanti; Piergiuseppe Cala'; Maria Calabrese
Journal:  Intern Emerg Med       Date:  2015-10-16       Impact factor: 3.397

2.  Strategies for preventing type 2 diabetes: an update for clinicians.

Authors:  Kaivan Khavandi; Halima Amer; Bashar Ibrahim; Jack Brownrigg
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

Review 3.  The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives.

Authors:  Lei Chen; Dianna J Magliano; Paul Z Zimmet
Journal:  Nat Rev Endocrinol       Date:  2011-11-08       Impact factor: 43.330

Review 4.  Diabetes prevention: can insulin secretagogues do the job?

Authors:  Barbara Westerhaus; Aidar R Gosmanov; Guillermo E Umpierrez
Journal:  Prim Care Diabetes       Date:  2010-12-24       Impact factor: 2.459

Review 5.  The Vasculature in Prediabetes.

Authors:  David H Wasserman; Thomas J Wang; Nancy J Brown
Journal:  Circ Res       Date:  2018-04-13       Impact factor: 17.367

6.  Profound defects in β-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the Early Diabetes Intervention Program (EDIP).

Authors:  Tamara S Hannon; M S Kirkman; Yash R Patel; Robert V Considine; Kieren J Mather
Journal:  Diabetes Metab Res Rev       Date:  2014-11       Impact factor: 4.876

7.  Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis.

Authors:  D H Morris; K Khunti; F Achana; B Srinivasan; L J Gray; M J Davies; D Webb
Journal:  Diabetologia       Date:  2013-04-13       Impact factor: 10.122

8.  Screening for impaired fasting glucose and diabetes using available health plan data.

Authors:  Laura N McEwen; Sara R Adams; Julie A Schmittdiel; Assiamira Ferrara; Joseph V Selby; William H Herman
Journal:  J Diabetes Complications       Date:  2013-04-12       Impact factor: 2.852

9.  Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program.

Authors:  Ann L Albright; Edward W Gregg
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

10.  Patient Perceptions About Prediabetes and Preferences for Diabetes Prevention.

Authors:  Matthew J O'Brien; Margaret R Moran; Joyce W Tang; Maria C Vargas; Mary Talen; Laura J Zimmermann; Ronald T Ackermann; Namratha R Kandula
Journal:  Diabetes Educ       Date:  2016-09-12       Impact factor: 2.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.